AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Melanoma research

Results: 126-150/396

Authors: EGGERMONT AMM
Citation: Amm. Eggermont, FOREWORD - THE EORTC-MELANOMA-COOPERATIVE-GROUP, Melanoma research, 7, 1997, pp. 1-1

Authors: FERRONE S
Citation: S. Ferrone, CARREL,STEFAN MEMORIAL ISSUE - INTRODUCTION, Melanoma research, 7, 1997, pp. 3-3

Authors: CEROTTINI JC LEJEUNE FJ
Citation: Jc. Cerottini et Fj. Lejeune, IN-MEMORIAM CARREL,STEFAN (1939-1996), Melanoma research, 7, 1997, pp. 5-5

Authors: DOUCET C MEAZZA R POTTINCLEMENCEAU C SCUDELETTI M BROUTYBOYE D FERRINI S ALILECHE A TAOUFIK Y JASMIN C AZZARONE B INDIVERI F
Citation: C. Doucet et al., ROLE OF INTERLEUKIN (IL)-2 AND IL-15 IN THE TUMOR PROGRESSION OF A MELANOMA CELL-LINE MELP, DERIVED FROM AN IL-2 PROGRESSOR PATIENT, Melanoma research, 7, 1997, pp. 7-17

Authors: ERHARD H RIETVELD FJR VANALTENA MC BROCKER EB RUITER DJ DEWAAL RMW
Citation: H. Erhard et al., TRANSITION OF HORIZONTAL TO VERTICAL GROWTH-PHASE MELANOMA IS ACCOMPANIED BY INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION ANDANGIOGENESIS, Melanoma research, 7, 1997, pp. 19-26

Authors: HARTMANN RR RIMOLDI D LEJEUNE FJ CARREL S
Citation: Rr. Hartmann et al., CELL-DIFFERENTIATION AND CELL-CYCLE ALTERATIONS BY TYROSINE KINASE INHIBITORS IN HUMAN-MELANOMA CELLS, Melanoma research, 7, 1997, pp. 27-33

Authors: SATYAMOORTHY K DEJESUS E LINNENBACH AJ KRAJ B KORNREICH DL RENDLE S ELDER DE HERLYN M
Citation: K. Satyamoorthy et al., MELANOMA CELL-LINES FROM DIFFERENT STAGES OF PROGRESSION AND THEIR BIOLOGICAL AND MOLECULAR ANALYSES, Melanoma research, 7, 1997, pp. 35-42

Authors: FURRER M ALTERMATT HJ RIS HB ALTHAUS U RUEGG C LIENARD D LEJEUNE FJ
Citation: M. Furrer et al., LACK OF ANTITUMOR-ACTIVITY OF HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA, ALONE OR IN COMBINATION WITH MELPHALAN IN A NUDE-MOUSE HUMAN-MELANOMA XENOGRAFT SYSTEM, Melanoma research, 7, 1997, pp. 43-49

Authors: BECKER JC TERHEYDEN P BROCKER EB
Citation: Jc. Becker et al., MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA, Melanoma research, 7, 1997, pp. 51-57

Authors: FARZAD Z MCBRIDE WH OGBECHI H ASNONGHOLTHOFF C MORTON DL COCHRAN AJ
Citation: Z. Farzad et al., LYMPHOCYTES FROM LYMPH-NODES AT DIFFERENT DISTANCES FROM HUMAN-MELANOMA VARY IN THEIR CAPACITY TO INHIBIT ENHANCE TUMOR-CELL GROWTH IN-VITRO/, Melanoma research, 7, 1997, pp. 59-65

Authors: HICKLIN DJ DELLARATTA DV KISHORE R LIANG B KAGESHITA T FERRONE S
Citation: Dj. Hicklin et al., BETA(2)-MICROGLOBULIN GENE-MUTATIONS IN HUMAN-MELANOMA CELLS - MOLECULAR CHARACTERIZATION AND IMPLICATIONS FOR IMMUNE SURVEILLANCE, Melanoma research, 7, 1997, pp. 67-74

Authors: KRAUS A MASAT L JOHNSON JP
Citation: A. Kraus et al., ANALYSIS OF THE EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 AND MUC18 ON BENIGN AND MALIGNANT MELANOCYTIC LESIONS USING MONOCLONAL-ANTIBODIES DIRECTED AGAINST DISTINCT EPITOPES AND RECOGNIZING DENATURED, NONGLYCOSYLATED ANTIGEN, Melanoma research, 7, 1997, pp. 75-81

Authors: LETHE B VANDERBRUGGEN P BRASSEUR F BOON T
Citation: B. Lethe et al., MAGE-1 EXPRESSION THRESHOLD FOR THE LYSIS OF MELANOMA CELL-LINES BY ASPECIFIC CYTOTOXIC T-LYMPHOCYTE, Melanoma research, 7, 1997, pp. 83-88

Authors: MINGARI MC PONTE M VITALE C SCHIAVETTI F BERTONE S MORETTA L
Citation: Mc. Mingari et al., EXPRESSION OF HLA CLASS I-SPECIFIC INHIBITORY RECEPTORS BY CHRONICALLY ACTIVATED CYTOLYTIC T-LYMPHOCYTES - USEFUL OR HARMFUL TO THE HOST, Melanoma research, 7, 1997, pp. 89-93

Authors: PARMIANI G ANICHINI A CASTELLI C
Citation: G. Parmiani et al., NEW TUMOR-RESTRICTED MELANOMA ANTIGENS AS DEFINED BY CYTOTOXIC T-CELLRESPONSES, Melanoma research, 7, 1997, pp. 95-98

Authors: REISFELD RA BECKER JC GILLIES SD
Citation: Ra. Reisfeld et al., IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA, Melanoma research, 7, 1997, pp. 99-106

Authors: VANELSAS A SCHEIBENBOGEN C VANDERMINNE C ZERP SF KEILHOLZ U SCHRIER PI
Citation: A. Vanelsas et al., UV-INDUCED N-RAS MUTATIONS ARE T-CELL TARGETS IN HUMAN-MELANOMA, Melanoma research, 7, 1997, pp. 107-113

Authors: AUTIER P DORE JF RENARD F LUTHER H CATTARUZZA MS GEFELLER O GRIVEGNEE A
Citation: P. Autier et al., MELANOMA AND SUNSCREEN USE - NEED FOR STUDIES REPRESENTATIVE OF ACTUAL BEHAVIORS, Melanoma research, 7, 1997, pp. 115-120

Authors: DORE JF MAISONNEUVE P CATTARUZZA MS AUTIER P COCHRAN AJ BOYLE P
Citation: Jf. Dore et al., A MOLECULAR EPIDEMIOLOGIC APPROACH TO THE STUDY OF EXPRESSION OF A METASTASIS MARKER IN PRIMARY MELANOMAS AND ITS CORRELATION WITH INDIVIDUAL PATIENTS RISK OF RECURRENCE OR METASTASIS, Melanoma research, 7, 1997, pp. 121-125

Authors: EGGERMONT AMM
Citation: Amm. Eggermont, THE CURRENT EORTC-MELANOMA-COOPERATIVE-GROUP ADJUVANT TRIAL PROGRAM ON MALIGNANT-MELANOMA - PROGNOSIS VERSUS EFFICACY, TOXICITY AND COSTS, Melanoma research, 7, 1997, pp. 127-131

Authors: KEILHOLZ U WILLHAUCK M SCHEIBENBOGEN C DEVRIES TJ BURCHILL S
Citation: U. Keilholz et al., POLYMERASE CHAIN-REACTION DETECTION OF CIRCULATING TUMOR-CELLS, Melanoma research, 7, 1997, pp. 133-141

Authors: KLEEBERG UR
Citation: Ur. Kleeberg, WISHFUL THINKING, UNICENTRIC EMPIRICISM AND THE EVERYDAY WORLD OF THEMEDICAL MELANOMOLOGIST, Melanoma research, 7, 1997, pp. 143-149

Authors: MACKIE RM
Citation: Rm. Mackie, SECONDARY PREVENTION OF CUTANEOUS MALIGNANT-MELANOMA, Melanoma research, 7, 1997, pp. 151-154

Authors: NASI ML MEYERS M LIVINGSTON PO HOUGHTON AN CHAPMAN PB
Citation: Ml. Nasi et al., ANTIMELANOMA EFFECTS OF R24, A MONOCLONAL-ANTIBODY AGAINST GD(3) GANGLIOSIDE, Melanoma research, 7, 1997, pp. 155-162

Authors: SMITH M BLEIJS R RADFORD K HERSEY P
Citation: M. Smith et al., IMMUNOGENICITY OF CD63 IN A PATIENT WITH MELANOMA, Melanoma research, 7, 1997, pp. 163-170
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>